A physiologically based pharmacokinetic computer model for human pregnancy.
A physiologically based pharmacokinetic (PBPK) model for human pregnancy must incorporate many factors that are not usually encountered in PBPK models of mature animals. Models for pregnancy must include the large changes that take place in the mother, the placenta and the embryo/fetus over the period of pregnancy. The embryo/fetal weight change was modeled using the Gompertz equation for growth which gave a good fit to extensive pooled weight data of the human embryo/fetus from 25 to 300 days of gestation. This equation is based on a growth rate that is proportional to the total weight of the organism with the proportionality factor decreasing exponentially with time. Allometric equations, which are widely used to relate organ weights, blood flow rates and other attributes of mature animals to total weight, were adapted to correlate fetal organ weights with total fetal weight. Allometric relationships were also developed for plasma flow rates and other organ-related parameters. The computer model, written in FORTRAN 77, included 27 compartments for the mother and 16 for the fetus; it also accommodates two substances allowing representation of a parent compound and a metabolite (or a second drug or environmental substance). Although this model is large, the inherent sparsity in the equations allow it to be solved numerically in a reasonable time on currently available, reasonably priced desktop computers. A nonlinear regression routine is included to fit key model parameters to experimental data. Concentrations of chemicals administered and measured in the mother may be simulated in both maternal and fetal organs at any day(s) between 25 days and 300 days of gestation. Allometric relationships are also utilized to adopt this human model for use with data obtained from animal experiments.
Luecke
R H
RH
Department of Chemical Engineering, University of Missouri-Columbia 65211.
Wosilait
W D
WD
Pearce
B A
BA
Young
J F
JF
D000014:Abnormalities, Drug-Induced / Q000196:embryology / Q000378:metabolism; D000818:Animals; D001825:Body Fluid Compartments; D003198:Computer Simulation; D004347:Drug Interactions; D005260:Female; D005333:Fetus / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000196:embryology / Q000378:metabolism; D008954:Models, Biological; D009929:Organ Size; D010599:Pharmacokinetics; D010920:Placenta / Q000187:drug effects / Q000378:metabolism; D011247:Pregnancy / Q000378:metabolism*; D012039:Regional Blood Flow; D013723:Teratogens / Q000493:pharmacokinetics; D014018:Tissue Distribution
D013723:Teratogens